Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,900.00
Bid: 3,900.00
Ask: 3,940.00
Change: -20.00 (-0.51%)
Spread: 40.00 (1.026%)
Open: 3,930.00
High: 3,930.00
Low: 3,900.00
Prev. Close: 3,920.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
8th Oct 20073:34 pmRNSDirector/PDMR Shareholding
8th Oct 20072:27 pmRNSHolding(s) in Company
1st Oct 20072:30 pmRNSHolding(s) in Company
28th Sep 20074:38 pmRNSHolding(s) in Company
28th Sep 20073:20 pmRNSDirector/PDMR Shareholding
25th Sep 20077:30 amRNSDirectorate Change
25th Sep 20077:30 amRNSInterim Results
14th Aug 200711:49 amRNSHolding(s) in Company
2nd Aug 20072:19 pmRNSPortfolio Update
30th Jul 20074:20 pmRNSDirector/PDMR Shareholding
24th Jul 20076:19 pmRNSHolding(s) in Company
24th Jul 20073:20 pmRNSHolding(s) in Company
6th Jul 200710:51 amRNSDirector/PDMR Shareholding
6th Jul 20079:32 amRNSTotal Voting Rights
27th Jun 20072:23 pmRNSHolding(s) in Company
27th Jun 20072:10 pmRNSAGM Statement
18th Jun 20073:31 pmRNSCancellation of CULS
15th Jun 200711:35 amRNSInterim Management Statement
31st May 20073:01 pmRNSHolding(s) in Company
31st May 200710:15 amRNSAnnual Information Update
31st May 20079:21 amRNSAnnual Report and Accounts
29th May 20075:01 pmRNSPortfolio Update
16th May 200711:39 amRNSDirector/PDMR Shareholding
16th May 200710:49 amRNSDirector/PDMR Shareholding
15th May 200711:56 amRNSFinal Results
1st May 20074:22 pmRNSPortfolio Update
10th Apr 20074:42 pmRNSDirector/PDMR Shareholding
27th Mar 20079:36 amRNSHolding(s) in Company
23rd Mar 20075:05 pmRNSHolding(s) in Company
21st Mar 200710:26 amRNSHolding(s) in Company
20th Mar 20073:46 pmRNSHolding(s) in Company
9th Mar 20077:00 amRNSHolding(s) in Company
28th Feb 20075:21 pmRNSInterests in Shares - AMENDED
27th Feb 20072:37 pmRNSInterests in Shares
23rd Feb 200710:37 amRNSHolding(s) in Company
6th Feb 20072:55 pmRNSHolding(s) in Company
2nd Feb 20071:50 pmRNSPortfolio Update
22nd Jan 200712:34 pmRNSRule 8.3- (ORYX )
12th Jan 20073:56 pmRNSDirector/PDMR S/hldg-Amend
12th Jan 20073:52 pmRNSDirector/PDMR S/hldg-Amend
12th Jan 20072:58 pmRNSDirector/PDMR Shareholding
12th Jan 20072:51 pmRNSDirector/PDMR Shareholding
9th Jan 20071:15 pmRNSDirector/PDMR Shareholding
5th Jan 200711:51 amRNSRule 8.3- (ORYX)
19th Dec 200611:27 amRNSTotal Voting Rights
7th Dec 200612:20 pmRNSCancellation of CULS
14th Nov 20063:58 pmRNSNotification of Interest
1st Nov 20063:34 pmRNSPortfolio Update
25th Oct 200611:59 amRNSDoc re. Interim Report
24th Oct 20063:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.